What is the next step in management for a 70-year-old female with bilateral grade II renal parenchymal changes and a pelvic cystic lesion with a mural nodule?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Pelvic Cystic Lesion with Mural Nodule in a 70-Year-Old Female with Renal Parenchymal Changes

The next step in management for this 70-year-old female should be an MRI of the pelvis and CA-125 testing as recommended in the ultrasound report, followed by gynecologic oncology consultation.

Assessment of Current Findings

Renal Findings

  • Bilateral grade II renal parenchymal changes with:
    • Increased parenchymal echotexture
    • Partial obliteration of corticomedullary differentiation (CMD)
    • Normal parenchymal thickness (14-15mm)
    • No hydronephrosis or calculi
  • These findings suggest chronic kidney disease that requires renal function testing (RFT) as recommended in the report

Pelvic Cystic Lesion

  • 10.0 × 7.4 cm well-defined thick-walled cyst superior to the bladder
  • Contains sedimented echogenic contents
  • Presence of a 6.9 mm isoechoic mural nodule
  • Location in the pelvis midline suggests possible ovarian origin, though the ovaries were not visualized separately

Diagnostic Workup

For the Pelvic Cystic Lesion

  1. MRI of the pelvis (highest priority)

    • Superior to ultrasound for characterizing complex cystic lesions 1
    • Can better define the origin of the mass (ovarian vs. other pelvic structures)
    • Can better characterize the mural nodule and internal components
  2. CA-125 testing

    • Important tumor marker for ovarian malignancy
    • Elevated levels may suggest malignant potential
    • Should be performed concurrently with MRI
  3. Gynecologic oncology consultation

    • Essential for evaluation of complex pelvic cystic lesions with suspicious features
    • The presence of a mural nodule increases concern for malignancy

For the Renal Parenchymal Changes

  1. Renal function testing
    • Complete metabolic panel including BUN, creatinine, eGFR
    • Urinalysis to assess for proteinuria and hematuria
    • These are recommended for monitoring of renal parenchymal disease 2, 1

Management Considerations

Pelvic Cystic Lesion

  • The presence of a mural nodule in a thick-walled cyst raises significant concern for malignancy
  • In a 70-year-old female, ovarian malignancy must be ruled out
  • If MRI confirms complex features, surgical evaluation is likely necessary
  • The differential diagnosis includes:
    • Ovarian cystadenoma/cystadenocarcinoma
    • Complex ovarian cyst
    • Other pelvic cystic lesions (less likely)

Renal Parenchymal Changes

  • Grade II renal parenchymal changes suggest moderate chronic kidney disease
  • Renal function must be considered when planning any interventions for the pelvic mass
  • Nephron-sparing approaches should be prioritized in any future interventions 2, 1
  • Regular monitoring of renal function is necessary

Follow-up Plan

  1. Short-term (1-2 weeks):

    • Complete MRI of pelvis and CA-125 testing
    • Renal function testing
    • Gynecologic oncology consultation
  2. Medium-term (based on initial results):

    • If suspicious for malignancy: surgical planning with consideration of renal function
    • If indeterminate: possible biopsy or short-interval follow-up imaging
    • If benign features: surveillance imaging
  3. Long-term:

    • Regular monitoring of renal function
    • Annual abdominal imaging to monitor both renal parenchymal changes and any residual or recurrent pelvic pathology

Pitfalls and Considerations

  • Diagnostic pitfalls: Pelvic cysts can sometimes be misidentified between renal and ovarian origin 3
  • Procedural considerations: Renal function must be considered when using contrast for MRI
  • Age-related factors: At 70 years old, the risk of malignancy in complex cystic lesions is higher
  • Comorbidity management: The bilateral renal parenchymal changes may impact treatment options and should be carefully evaluated

The presence of both a suspicious pelvic cystic lesion with a mural nodule and bilateral renal parenchymal changes requires careful coordination between gynecologic oncology and nephrology to ensure optimal management of both conditions.

References

Guideline

Management of Complex Renal Cysts

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pelvic cyst: renal or ovarian?

Journal of minimally invasive gynecology, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.